Pathophysiology of ST-segment elevation myocardial infarction: Novel mechanisms and treatments

Keyphrases

• Acute Myocardial Infarction 33%
• Anti-inflammatory Drugs 33%
• Atrial Natriuretic Peptide 33%
• Cardiac Stem Cells 33%
• Cardioprotection 33%
• Clinical Outcomes 33%
• Cyclosporine 33%
• Detection Method 33%
• Early Detection 33%
• Exenatide 33%
• High-sensitive Troponin 33%
• Hypoxemia 33%
• Improved Outcomes 33%
• Infarct Size 100%
• Ischemia-reperfusion Injury 33%
• Ischemic Preconditioning 33%
• Left Ventricle 33%
• Morbidity Burden 33%
• Mortality Burden 33%
• Myocardial Infarction 66%
• Myocardial Ischemia 33%
• Myocardial Ischemia-reperfusion 33%
• Myocardial Ischemia-reperfusion Injury 33%
• Negative Remodeling 33%
• Novel Mechanism 100%
• Novel Treatments 100%
• Pathophysiology 100%
• Pharmacological Intervention 33%
• Remote Ischemic Preconditioning 33%
• Reperfusion Strategy 66%
• Socioeconomic Burden 33%
• ST-elevation Myocardial Infarction (STEMI) 100%
• Stem Cell Therapy 33%
• Therapeutic Hypothermia 33%
• Troponin Assay 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Heart Infarction 33%
• Anti-Inflammatory Drug 33%
• Atrial Natriuretic Factor 33%
• Ciclosporin 33%
• Exendin 4 33%
• Heart Infarction 33%
• Heart Muscle Ischemia 33%
• Hypothermia 33%
• Hypoxemia 33%
• Infarction 100%
• Myocardial Ischemia Reperfusion Injury 33%
• Pathophysiology 100%
• Reperfusion Injury 33%
• ST Segment Elevation Myocardial Infarction 100%
• Troponin 33%